ARCT ARCTURUS THERAPEUTICS HOLDIN
2026Q1 · CUSIP 03969T109 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
124
Δ holders QoQ
+3
Breadth percentile
Top 50%
Whale holders
68
Δ whales
-3
Inst. holding value
$186M
New positions
28
Closed positions
25
Price momentum (1Q)
-5.0%
Put / Call
2/4
Breadth history (34 quarters)
Past Lit Events & Aftermath 8 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2023Q2 | Top 10% | -31.1% | +35.6% |
| 2023Q1 | Top 18% | -1.1% | -20.5% |
| 2021Q3 | Top 11% | -34.5% | -55.6% |
| 2021Q1 | Top 10% | +62.8% | +30.7% |
| 2020Q3 | Top 19% | +27.6% | -42.0% |
| 2020Q2 | Top 3% | -11.8% | +25.0% |
| 2020Q1 | Top 19% | — | — |
| 2019Q3 | Top 8% | — | — |
Options Sentiment
Put holders
2
QoQ: -4
Call holders
4
QoQ: -2
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-2.83
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
-61.9%
Net margin
-143.8%
ROE
-41.1%
Debt ratio
22.0%
FCF (TTM)
-$59M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.